Skip to main content
OpenTrials
Completed

NCT Number: NCT01436383

Oxidative Stress in Hypobaric Hypoxia

The trial investigates changes in metabolism during high altitude expedition up to 6865m. A mass-spectrometry based platform is used to detect different oxidative stress related metabolites. Symptoms of acute mountain sickness are evaluated and correlated with laboratory parameters.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Center of Laboratory Medicine

Aarau, 5001, Switzerland

About this study

Background

Altitude related illness, which include acute mountain sickness (AMS), high altitude pulmonary edema (HAPE) and high altitude cerebral edema (HACE), is common in subjects exposed to high altitude during professional or leisure time activities. There are independent risk factors such as: individual susceptibility and rate of ascent. HAPE is a potentially life-threatening complication of high altitude stay, mostly occuring within the first 2-5 days of exposure. Although there is a controversial discussion, excessive hypoxic pulmonary vasoconstriction is thought to be the main trigger for developing HAPE. Beside the controversial discussion if hypobaric hypoxia leads to oxidative stress it is not known whether oxidative stress contributes to AMS or HAPE.

Objective

The investigators hypothesize that reactive oxygen species are generated during high altitude stay and contribute to the development of acute mountain sickness. Furthermore they would like to describe other changes in metabolic pathways possibly contributing to vessel tone dysregulation.

Methods

36 healthy volunteers will examined during an high altitude medical research expedition to Mount Muztagh ata (7549m) in Western China. Acute mountain sickness scores and clinical parameters will be assessed. Metabolomics analysis of more than 390 parameters, using a mass spectrometry-based targeted metabolomic platform, is used to detect systemic oxidative stress and functional impairment of enzymes that require oxidation-sensitive co-factors. Furthermore routine laboratory test will be done, for example CRP, creatinine and interleukines

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • healthy
  • physical fit
  • mountaineering experience
  • 18-70 years

Exclusion criteria

  • any type of disease
  • regular intake of medicaments
  • history of high altitude pulmonary edema
  • severe acute mountain sickness below an altitude of 3500m
  • any history of high altitude cerebral edema

Treatment and study plan

Hypoxic exposure

Other

Hypoxic exposure

Primary outcomes

  1. Number of volunteers with acute mountain sickness

    Time frame: during ascent, expected to be approximately 19-23 days

Secondary outcomes

  1. Change from baseline in oxygen saturation in blood

    Time frame: during ascent, expected to be approximately 19-23 days

  2. Changes from baseline in oxidative stress

    Time frame: during ascent, expected to be approximately 19-23 days

  3. Changes from baseline in different metabolic pathways

    Time frame: during ascent, expected to be approximately 19-23 days

Sponsors and collaborators

Lead sponsor

Insel Gruppe AG, University Hospital Bern

Other

Collaborators

  • Kantonsspital Aarau
  • Swiss National Science Foundation

Registry information

Official study title

Oxidative Stress in Hypobaric Hypoxia and Influence on Vessel-tone Modifying Mediators

Important dates

Study start
2005
Primary completion
2005
Study completion
2010
First posted
Sep 19, 2011
Registry last updated
Sep 21, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.